Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Jiří, Petera"'
Autor:
Iveta Kolářová, Bohuslav Melichar, Igor Sirák, Jaroslav Vaňásek, Jiří Petera, Kateřina Horáčková, Denisa Pohanková, Filip Ďatelinka, Zuzana Šinkorová, Milan Vošmik
Publikováno v:
Current Oncology, Vol 31, Iss 3, Pp 1207-1220 (2024)
The role of postmastectomy radiotherapy and regional nodal irradiation after radical mastectomy is defined in high-risk patients with locally advanced tumors, positive margins, and unfavorable biology. The benefit of postmastectomy radiotherapy in in
Externí odkaz:
https://doaj.org/article/fc0a53d8646a410ba62dda07b6301b90
Autor:
Ondřej Kubeček, Jan Laco, Jiří Špaček, Alena Kubečková, Jiří Petera, Iva Selke Krulichová, Aleš Bezrouk, Stanislav Filip, Jindřich Kopecký
Publikováno v:
Current Oncology, Vol 28, Iss 4, Pp 2914-2927 (2021)
Background: Secondary tumors of the ovary (STOs) account for 10–25% of all ovarian malignancies, including metastases from primary gynecological tumors. Colorectal cancer (CRC) has been recognized as one of the most common causes of STOs in Western
Externí odkaz:
https://doaj.org/article/624e3aa44f564ab48754237d1a22b50b
Publikováno v:
Onkologie. 16:312-316
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca16084733ab869cc31ac00c07392e18
https://doi.org/10.36290/xon.2022.066
https://doi.org/10.36290/xon.2022.066
Autor:
Luboš Tuček, Igor Sirák, Miroslav Hodek, Linda Kašaová, Jakub Grepl, Petr Paluska, Denisa Pohanková, Libor Hruška, Milan Vošmik, Jiří Petera
Publikováno v:
Brachytherapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36125d96b9e715af9406a2bd092248e6
https://doi.org/10.1016/j.brachy.2023.02.001
https://doi.org/10.1016/j.brachy.2023.02.001
Publikováno v:
Acta Medica, Vol 59, Iss 2, Pp 54-58 (2016)
The aims of the study were: i) to compare circulating tumor DNA (ctDNA) yields obtained by different manual extraction procedures, ii) to evaluate the addition of various carrier molecules into the plasma to improve ctDNA extraction recovery, and iii
Externí odkaz:
https://doaj.org/article/bc43884ee9864667a2ed0b2b7052111a
Autor:
Denisa Pohanková, Igor Sirák, Milan Vošmik, Linda Kašaová, Jakub Grepl, Petr Paluska, Lukáš Holub, Jiří Špaček, Miroslav Hodek, Martin Kopeček, Jiří Petera
Publikováno v:
Cancers; Volume 14; Issue 24; Pages: 6248
Background: Low-dose-rate brachytherapy is an effective organ-sparing treatment for patients with early-stage penile cancer. However, only limited data are available on the role of high-dose-rate brachytherapy (HDR-BT) in this clinical setting. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b07c45309451f311093fa72ff1d2d72e
Autor:
Veronika Novotná, Jakub Grepl, Petr Motyčka, Jiří Petera, Ahmed Asqar, Lucie Kretzler, Linda Kašaová, Denisa Pohanková, Igor Sirák, Pavel Jandík, Petr Paluska
Publikováno v:
Strahlentherapie und Onkologie. 197:288-295
To quantify mean heart dose (MHD) and doses to the left anterior descending artery (LAD) and left ventricle (LV) in a retrospective series of patients who underwent perioperative accelerated partial breast irradiation with multicatheter interstitial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::403b08b8f12b26491b4bbdcda7c3ff3c
https://doi.org/10.1007/s00066-020-01699-5
https://doi.org/10.1007/s00066-020-01699-5
Publikováno v:
Onkologie. 14:13-17
Východiska: Chemoterapie (CHT) je důležitou modalitou využivanou v lecbě nadorových onemocněni. V užsim smyslu se pod pojmem chemoterapie rozumi lecba cytostatiky. Tato lecba je spojena s množstvim nežadoucich ucinků (NU), ktere jsme v sou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba95fec7d377a2a3d1a42e0a0979e5bb
https://doi.org/10.36290/xon.2020.050
https://doi.org/10.36290/xon.2020.050
Publikováno v:
Acta Medica, Vol 55, Iss 4, Pp 160-164 (2012)
Dideoxynucleotide DNA sequencing is one of the principal procedures in molecular biology. Loss of an initial part of nucleotides behind the 3' end of the sequencing primer limits the readability of sequenced amplicons. We present a method which exten
Externí odkaz:
https://doaj.org/article/6833c386fb5545558644b2a0bd013010
Publikováno v:
Acta Medica, Vol 54, Iss 3, Pp 111-116 (2011)
Clinical oncologists have been focusing their efforts on attempting to define risk groups of patients with unusual biological reactions to the recommended therapy regimens using molecular biology techniques. The aims of our study were: (i) to find a
Externí odkaz:
https://doaj.org/article/20012835f96240ccbd174916fbcf15f9